Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Flockhart

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Clinical Advances in Hematology & Oncology : H&O|July 26, 2008
CYP2D6 genotyping and the pharmacogenetics of tamoxifenDavid Flockhart
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 11, 2007
Flash pointsJanet S Carpenter, David Flockhart
Journal of Psychiatric Practice|August 3, 2006
Clinically relevant pharmacology of neuropsychiatric drugs approved over the last three years: part ISheldon H Preskorn, Silvana Borges, David Flockhart
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 4, 2014
One size fits one: pharmacogenetics in gastroenterologyPrashanth Porayette, David Flockhart, Sandeep K Gupta
Journal of Psychiatric Practice|September 26, 2006
Clinically relevant pharmacology of neuropsychiatric drugs approved over the last three years: Part IISheldon H Preskorn, Silvana Borges-Gonzalez, David Flockhart
Statistics in Medicine|August 19, 2004
QT analysis: a complex answer to a 'simple' problemLang Li, Mehul Desai, Zeruesenay Desta, et al.
Virologie (Montrouge, France)|September 24, 2022
[Importance of pharmacogenetics in antiretroviral metabolism and drug-transporters]Véronique Michaud, Jacques Turgeon, David Flockhart, et al.
Journal of the National Cancer Institute|May 1, 2008
A model citizen? Is tamoxifen more effective than aromatase inhibitors if we pick the right patients?Daniel F Hayes, Vered Stearns, James Rae, et al.
British Journal of Clinical Pharmacology|June 20, 2003
Variability of heart rate correction methods for the QT intervalMehul Desai, Lang Li, Zeruesenay Desta, et al.
British Journal of Clinical Pharmacology|February 5, 2016
Big Data: Challenges and opportunities for clinical pharmacologyDavid Flockhart, Robert R Bies, Marc R Gastonguay, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Clinical Advances in Hematology & Oncology : H&O|July 26, 2008
CYP2D6 genotyping and the pharmacogenetics of tamoxifenDavid Flockhart
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 11, 2007
Flash pointsJanet S Carpenter, David Flockhart
Journal of Psychiatric Practice|August 3, 2006
Clinically relevant pharmacology of neuropsychiatric drugs approved over the last three years: part ISheldon H Preskorn, Silvana Borges, David Flockhart
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 4, 2014
One size fits one: pharmacogenetics in gastroenterologyPrashanth Porayette, David Flockhart, Sandeep K Gupta
Journal of Psychiatric Practice|September 26, 2006
Clinically relevant pharmacology of neuropsychiatric drugs approved over the last three years: Part IISheldon H Preskorn, Silvana Borges-Gonzalez, David Flockhart
Statistics in Medicine|August 19, 2004
QT analysis: a complex answer to a 'simple' problemLang Li, Mehul Desai, Zeruesenay Desta, et al.
Virologie (Montrouge, France)|September 24, 2022
[Importance of pharmacogenetics in antiretroviral metabolism and drug-transporters]Véronique Michaud, Jacques Turgeon, David Flockhart, et al.
Journal of the National Cancer Institute|May 1, 2008
A model citizen? Is tamoxifen more effective than aromatase inhibitors if we pick the right patients?Daniel F Hayes, Vered Stearns, James Rae, et al.
British Journal of Clinical Pharmacology|June 20, 2003
Variability of heart rate correction methods for the QT intervalMehul Desai, Lang Li, Zeruesenay Desta, et al.
British Journal of Clinical Pharmacology|February 5, 2016
Big Data: Challenges and opportunities for clinical pharmacologyDavid Flockhart, Robert R Bies, Marc R Gastonguay, et al.
Pageof 3